MyStocks

MEMBER'S LOGINX

Remember Username
Keep me signed in

(Please do not use this option on a public machine)

Print
Text -Size
RSS
FaceBook
Twitter
Linked In
WhatsApp

Home
Todays Market
Indian Stock Market Updates March 16, 2020

The BSE FMCG Index Down 2% ; GUJ.AMB.EXP. Among Top Losers
Mon, 16 Mar 09:26 AM

The BSE FMCG Index has plunged 2% to 9,702.

Among the top losers in the BSE FMCG Index today are GUJ.AMB.EXP. (down 9.3%), RADICO KHAITAN (down 9.1%) and DFM FOODS (down 7.8%). Other losers include BALRAMPUR CHINI (down 7.7%) and DHAMPUR SUGAR MILLS (down 7.5%).

VADILAL INDUSTRIES (up 7.8%) and KOKUYO CAMLIN (up 7.2%) are among the top gainers today.

In the meantime, the NIFTY FMCG has plunged 3.9% to 25,624.

The top losers in the NIFTY FMCG include REI AGRO LTD. (down 20.0%), MIC ELECTRONICS (down 10.0%) and EMAMI LTD (down 5.7%). Other losers include TAMILNADU PETROPRODUCTS (down 5.6%) and PG ELECTROPLAST (down 5.0%).

Over the last one year, the BSE FMCG Index has moved down from 11,815 to 9,702, loss of Rs 2,113 (down 17.9%).

The top losers among the BSE FMCG during this same period were MCLEOD RUSSEL (down 97.3%), MANPASAND BEVERAGES (down 93.4%) and SANWARIA AGRO OILS (down 88.8%).

What about the Benchmark Indices?

Meanwhile, the BSE Sensex has plunged 4.4% to 33,103.

Among the top gainers in the BSE Sensex today .

The most traded stocks in the BSE Sensex is SUN PHARMA.

In the meantime, the NSE Nifty is at 9,593 (down 5.2%).

Stock Market Updates

Volatile Day for Indian Indices: Sensex Ends 131 Points Lower Post Rebound; Telecom and Auto Stocks Bleed (Today's Market)

Mar 27, 2020 Closing

It was a volatile day for India share markets today. The benchmark indices opened higher but turned volatile.

DR. LAL PATHLABS LTD Surges by 5%; BSE HEALTHCARE Index Up 0.5% (Today's Market)

Mar 27, 2020 03:34 PM

DR. LAL PATHLABS LTD share price has surged by 5% and its current market price is Rs 1,571. The BSE HEALTHCARE is up by 0.5%. The top gainers in the BSE HEALTHCARE Index are DR. LAL PATHLABS LTD (up 5.2%) and AJANTA PHARMA (up 6.2%). The top losers are ALEMBIC PHARMA (down 0.1%) and DR. REDDYS LAB (down 0.2%).

TEAMLEASE SERVICES Plunges by 10%; BSE 500 Index Down 0.2% (Today's Market)

Mar 27, 2020 03:34 PM

TEAMLEASE SERVICES share price has plunged by 10% and its current market price is Rs 1,777. The BSE 500 is down by 0.2%. The top gainers in the BSE 500 Index are SHRIRAM TRANSPORT (up 12.6%) and MMTC LTD (up 12.2%). The top losers are TEAMLEASE SERVICES (down 10.2%) and MAHARASHTRA SEAMLESS (down 14.4%).

NESCO Plunges by 6%; BSE CAPITAL GOODS Index Down 0.3% (Today's Market)

Mar 27, 2020 03:30 PM

NESCO share price has plunged by 6% and its current market price is Rs 520. The BSE CAPITAL GOODS is down by 0.3%. The top gainers in the BSE CAPITAL GOODS Index are BHARAT ELECTRONICS (up 9.0%) and FINOLEX CABLES (up 6.6%). The top losers are NESCO (down 5.9%) and AIA ENGINEERING (down 5.3%).

SIEMENS Plunges by 5%; BSE CAPITAL GOODS Index Down 0.3% (Today's Market)

Mar 27, 2020 03:18 PM

SIEMENS share price has plunged by 5% and its current market price is Rs 1,165. The BSE CAPITAL GOODS is down by 0.3%. The top gainers in the BSE CAPITAL GOODS Index are BHARAT ELECTRONICS (up 8.7%) and FINOLEX CABLES (up 6.7%). The top losers is SIEMENS (down 5.1%).

PFIZER Plunges by 5%; BSE HEALTHCARE Index Down 0.4% (Today's Market)

Mar 27, 2020 03:12 PM

PFIZER share price has plunged by 5% and its current market price is Rs 4,000. The BSE HEALTHCARE is down by 0.4%. The top gainers in the BSE HEALTHCARE Index are GRANULES INDIA (up 10.6%) and CAPLIN POINT (up 7.4%). The top losers are PFIZER (down 5.2%) and APOLLO HOSPITALS (down 6.0%).

View More Indian Share Market News

Most Popular

This Crorepati Stock Could Be the Best Vaccine for Your Portfolio Against Coronavirus(Profit Hunter)

Mar 17, 2020

If there is one stock I had to recommend you amid Coronavirus outbreak, this would be it.

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It.(Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World(The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Real Long-Term Impact of the Coronavirus on India(The 5 Minute Wrapup)

Mar 18, 2020

My view on the impact of the Coronavirus on the Indian economy.

How to Trade the Coronavirus Crash - Download this FREE Report Now
How to Profit Even During These Times of Crisis: Vijay Bhambwani Reveals his Strategy...
The Best Stocks For 2020 - How to Spot Multibagger Ideas. FREE Sign up!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

S&P BSE SENSEX

29,815.59 -0.44%
Mar 27, 2020 (Close)

MARKET STATS

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS

PREMIUM PRODUCTS

QUICK LINKS

APPS

FOLLOW

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Testimonials